ea0094p169 | Adrenal and Cardiovascular | SFEBES2023
Miller Madelaine
, Lazarus Katharine
, Choudhury Sirazum
, Peters Debbie
, Tan Tricia
, Meeran Karim
Background: Patients with adrenal insufficiency (AI) require glucocorticoid replacement therapy. Current Endocrine Society guidelines recommend thrice-daily hydrocortisone (15-25mg) or once-daily prednisolone (3-5mg). Concerns around prednisolone use have been based on evidence using higher doses. We have been using low-dose (2-4mg) once-daily prednisolone since 2014 for glucocorticoid replacement in adult patients with AI. This study aimed to compare the effe...